{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T04:51:08Z","timestamp":1686199868517},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.beha.2011.05.007","type":"journal-article","created":{"date-parts":[[2011,7,15]],"date-time":"2011-07-15T00:22:40Z","timestamp":1310689360000},"page":"393-401","source":"Crossref","is-referenced-by-count":2,"title":["Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: The role of ex-vivo generated donor CD8+ T cells with central memory phenotype"],"prefix":"10.1016","volume":"24","author":[{"given":"Eran","family":"Ophir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaki","family":"Eidelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esti","family":"Bachar-Lustig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hagin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noga","family":"Or-Geva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assaf","family":"Lask","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Reisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2011.05.007_bib1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0140-6736(86)91503-5","article-title":"Graft rejection and graft-versus-host disease: mirror images","volume":"1","author":"Gale","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2011.05.007_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/00007890-198743060-00014","article-title":"Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes","volume":"43","author":"Kernan","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2011.05.007_bib3","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.83.11.4012","article-title":"Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation","volume":"83","author":"Reisner","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2011.05.007_bib4","first-page":"357","article-title":"Residual clonable host cell detection for predicting engraftment of T cell depleted BMTs","volume":"11","author":"Terenzi","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2011.05.007_bib5","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V73.7.2025.2025","article-title":"Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts","volume":"73","author":"Lapidot","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm1295-1268","article-title":"Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice","volume":"1","author":"Bachar-Lustig","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2011.05.007_bib7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood.V79.6.1612.1612","article-title":"Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation","volume":"79","author":"Uharek","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib8","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \"three-loci\" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0167-5699(95)80021-2","article-title":"Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells","volume":"16","author":"Reisner","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.beha.2011.05.007_bib10","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.05.007_bib11","first-page":"414","article-title":"Haploidentical transplantation for adults with poor prognostic hematologic malignancies using the Perugia approach","volume":"16","author":"Redei","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.05.007_bib12","first-page":"417","article-title":"Haploidentical transplantation - a single center experience","volume":"16","author":"Zuckerman","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.05.007_bib13","first-page":"410","article-title":"Haploidentical transplantation in children with hematological malignancies and non-malignant disorders. A single center 5-year experience","volume":"16","author":"Handgretinger","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.05.007_bib14","first-page":"408","article-title":"Haploidenticl stem cell transplantation in children","volume":"6","author":"Cornish","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.05.007_bib15","first-page":"410","article-title":"Haploidentical stem cell transplantation in children","volume":"16","author":"Klingebiel","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.05.007_bib16","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/00007890-199805270-00017","article-title":"Tolerance induction by \"megadose\" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture","volume":"65","author":"Rachamim","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2011.05.007_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/287544a0","article-title":"An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it","volume":"287","author":"Miller","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.beha.2011.05.007_bib18","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2002-11-3463","article-title":"Immune regulatory activity of CD34\u00a0+\u00a0progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha","volume":"105","author":"Gur","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib19","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1182\/blood.V99.11.4174","article-title":"Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells","volume":"99","author":"Gur","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib20","doi-asserted-by":"crossref","first-page":"a65","DOI":"10.1182\/blood.V114.22.65.65","article-title":"Tolerance induction by immature dendritic cells is mediated by distinct MHC dependent and independent mechanisms: a novel role for perforin, granzyme A and toll like receptor 7","volume":"114","author":"Zangi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib21","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.4049\/jimmunol.173.11.6654","article-title":"Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells","volume":"173","author":"Reich-Zeliger","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cimm.2001.1771","article-title":"Veto activity of activated bone marrow does not require perforin and Fas ligand","volume":"208","author":"Chrobak","year":"2001","journal-title":"Cell Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/shem.2002.29255","article-title":"Transplants across human leukocyte antigen barriers","volume":"39","author":"Martelli","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1016\/j.beha.2011.05.007_bib24","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood-2009-12-234096","article-title":"Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update","volume":"115","author":"Seggewiss","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib25","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1182\/blood.V99.12.4592","article-title":"Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation","volume":"99","author":"Min","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/1078-0432.CCR-07-1784","article-title":"Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade","volume":"14","author":"Sutherland","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2011.05.007_bib27","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1182\/blood-2008-01-136531","article-title":"Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation","volume":"111","author":"Kelly","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib28","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib29","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bcmd.2007.06.022","article-title":"Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation","volume":"40","author":"Perruccio","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.beha.2011.05.007_bib31","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-02-001909","article-title":"Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation","volume":"108","author":"Amrolia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbmt.2007.04.005","article-title":"Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation","volume":"13","author":"Tey","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2011.05.007_bib33","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood-2008-05-156059","article-title":"IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes","volume":"113","author":"Kaneko","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib34","article-title":"The great debate: haploidentical or cord blood transplant","author":"Ballen","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2011.05.007_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/ehm.10.21","article-title":"Allogeneic hematopoietic cell transplantation: the state of the art","volume":"3","author":"Gyurkocza","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.beha.2011.05.007_bib36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbmt.2009.04.006","article-title":"A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD","volume":"15","author":"Guo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2011.05.007_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using post transplantation cyclophosphamide","volume":"8","author":"O\u2019Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2011.05.007_bib38","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2006.06.007","article-title":"Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning","volume":"12","author":"Ogawa","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2011.05.007_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcmd.2007.07.001","article-title":"Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3\/CD19 depletion and reduced intensity conditioning: an update","volume":"40","author":"Bethge","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.beha.2011.05.007_bib40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-2005-872529","article-title":"A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study","volume":"217","author":"Lang","year":"2005","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.beha.2011.05.007_bib41","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.intimp.2008.12.009","article-title":"Induction of tolerance in organ recipients by hematopoietic stem cell transplantation","volume":"9","author":"Ophir","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.beha.2011.05.007_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1084\/jem.169.2.493","article-title":"Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen","volume":"169","author":"Sharabi","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2011.05.007_bib43","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.153.3.1087","article-title":"Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen","volume":"153","author":"Tomita","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00007890-199602150-00027","article-title":"Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation","volume":"61","author":"Tomita","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2011.05.007_bib45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/74731","article-title":"Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment","volume":"6","author":"Wekerle","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2011.05.007_bib46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa071074","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression","volume":"358","author":"Kawai","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2011.05.007_bib47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa074191","article-title":"Tolerance and chimerism after renal and hematopoietic-cell transplantation","volume":"358","author":"Scandling","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2011.05.007_bib48","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood.V94.9.3212","article-title":"Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1(+)Lin(-) bone marrow progenitor cells: synergism with non-alloreactive (host x donor)F(1) T cells","volume":"94","author":"Bachar-Lustig","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-3083.1989.tb01150.x","article-title":"Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. III. Direct correlation between development of syngeneic cytotoxicity and loss of veto activity; implications for the mechanism of veto action","volume":"29","author":"Claesson","year":"1989","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib50","first-page":"213","article-title":"Antiself suppressive (veto) activity of responder cells in mixed lymphocyte cultures","volume":"126","author":"Claesson","year":"1986","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib51","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4049\/jimmunol.133.4.1769","article-title":"Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes","volume":"133","author":"Fink","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib52","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.4049\/jimmunol.173.11.6660","article-title":"Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis","volume":"173","author":"Reich-Zeliger","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1074-7613(00)00050-9","article-title":"Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite","volume":"13","author":"Reich-Zeliger","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.beha.2011.05.007_bib54","article-title":"CTLs respond with activation and granule secretion when serving target for T cell recognition","author":"Milstein","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib55","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood.V80.9.2406.bloodjournal8092406","article-title":"Enhancement of T-cell-depleted bone marrow allografts in the absence of graft-versus-host disease is mediated by CD8+ CD4- and not by CD8- CD4+ thymocytes","volume":"80","author":"Lapidot","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib56","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood.V88.3.962.962","article-title":"Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism","volume":"88","author":"Martin","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib57","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood-2003-03-0759","article-title":"Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose","volume":"102","author":"Bachar-Lustig","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.tp.0000185302.38890.6b","article-title":"Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cells","volume":"81","author":"Anderson","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.beha.2011.05.007_bib59","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1073\/pnas.0503726102","article-title":"Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells","volume":"102","author":"Klebanoff","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2011.05.007_bib60","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1172\/JCI13296","article-title":"Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes","volume":"108","author":"Manjunath","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2011.05.007_bib61","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.4049\/jimmunol.172.12.7315","article-title":"Initial antigen encounter programs CD8+ T cells competent to develop into memory cells that are activated in an antigen-free, IL-7- and IL-15-rich environment","volume":"172","author":"Carrio","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib62","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.beha.2011.05.007_bib63","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.194.7.953","article-title":"Migratory properties of naive, effector, and memory CD8(+) T cells","volume":"194","author":"Weninger","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2011.05.007_bib64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib65","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/eji.200838426","article-title":"Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy","volume":"38","author":"Mueller","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.beha.2011.05.007_bib66","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2009-10-248716","article-title":"Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex\u00a0vivo-induced central memory CD8 T cells","volume":"115","author":"Ophir","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib67","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2003-03-0982","article-title":"Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs","volume":"105","author":"Arditti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib68","doi-asserted-by":"crossref","first-page":"a2759","DOI":"10.1182\/blood.V110.11.2759.2759","article-title":"Eradication of B cell malignancies by anti-3rd party CTLs: a novel role for MHC class I","volume":"10","author":"Assaf Lask","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.05.007_bib69","doi-asserted-by":"crossref","first-page":"a424","DOI":"10.1182\/blood.V116.21.424.424","article-title":"Ex vivo generated donor central memory CD8 T Cells, previously shown to enhance engraftment of allogeneic bone marrow, also exhibit significant GVL activity without causing Gvhd in an in\u00a0vivo b cell lymphoma model","volume":"116","author":"Assaf Lask","year":"2010","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169261100065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169261100065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T04:04:22Z","timestamp":1686197062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169261100065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S152169261100065X"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2011.05.007","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}